Purpose: Few studies have reported postdiagnosis differences in distress and quality of life (QOL) for breast cancer (BC) survivors. Here we investigated the differences in distress and QOL for BC survivors in Korea, during follow-up. Methods: Completed questionnaires were collected from 179 BC survivors in 2013. Functional Assessment of Cancer Therapy-Breast was administered to measure the distress and Distress Thermometer and Problem List was administered to measure the QOL. Results: The mean QOL score was 96.69 (standard deviation, ± 20.33). Seventy-nine patients (44.1%) with distress-test scores > 4 were assigned to the severe distress group. The patient group with higher family income had high QOL score (p= 0.008). In addition, QOL scores were significantly higher in patients who lived longer after diagnosis (p= 0.016). Patients at high TNM stage had low QOL scores (p= 0.006). Furthermore, older patients tended to have high distress scores (p= 0.028). Based on duration of the postdiagnosis period, we divided the patients into two groups. Seventy patients had a postdiagnosis period < 2 years; 109 patients, postdiagnosis period ≥ 2 years. Distress score of the under-2-year group (4.26± 2.73) was significantly higher (p= 0.044) than that of the longer-than-2-year group (3.47± 2.42). Conclusion: BC survivors showed improvement in physical well-being, emotional well-being, and functional well-being domain of QOL over time. However, social well-being and BC subscale score were only slightly improved over time. It is possible that cancer patients' supporting programs are focused on the recently diagnosed patients or those currently undergoing treatment. Therefore, more support should be made available to long-term BC survivors.

